-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH and the ASH Research Collaborative: Advancing Progress in Sickle Cell Disease (for in-person participants)

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Monday, December 11, 2023: 6:15 PM-8:00 PM
Room 28 A-D & Plaza Terrace (San Diego Convention Center)
Meeting attendees with an interest in sickle cell are invited to this reception, which will celebrate progress in sickle cell and provide an opportunity to network.  Through the Sickle Cell Disease (SCD) Initiative, ASH and the ASH Research Collaborative (ASH RC) have made significant progress in 2023 to support advances in research, improving provider training and education, advocating for policies to expand access to care, and enhancing data collection.  The program will feature Dr. Mohandas Narla, ASH President-Elect, and Dr. Alexis Thompson, Chair of the ASH Research Collaborative SCD Data Hub, and SCD Learning Community Subcommittees, presenting a brief snapshot of the advances the ASH and the ASH RC have made to drive change in sickle cell disease over the past year. The remaining part of the program will provide ample time for networking.